CPSF4 Promotes Tumor-Initiating Phenotype by Enhancing VEGF/NRP2/TAZ Signaling in Lung Cancer

The authors demonstrated that cleavage and polyadenylation specificity factor 4 (CPSF4) promoted tumor-initiating phenotype and conferred chemoresistance to paclitaxel both in vitro and in vivo.